Ingovax Acwy Vaccine 0.5ml

✔️ Each 0.5 mL dose, after reconstitution, contains:

• Group A polysaccharide: 5 µg
• Group C polysaccharide: 5 µg
• Group W-135 polysaccharide: 5 µg
• Group Y polysaccharide: 5 µg
• Tetanus toxoid carrier protein: 44 µg

✔️ Common Side Effects

• Metabolism and nutrition disorders: Appetite loss
• Psychiatric disorders: Irritability
• Nervous system disorders: Drowsiness, headache
• Gastrointestinal issues: Nausea, vomiting, diarrhea
• Musculoskeletal pain: Myalgia
• General symptoms: Pain, redness, swelling at the injection site, fatigue, fever

✔️ Mode of Action

The vaccine contains capsular polysaccharides from meningococcal serogroups A, C, Y, and W-135, conjugated to a diphtheria toxoid protein carrier. This combination stimulates the immune system to produce protective antibodies, providing active immunity.

✔️ Dosage and Administration

Adults

• A single dose of 0.5 mL, was administered subcutaneously.
• Protective antibody levels are typically achieved within 7 to 10 days after vaccination.

Primary Immunization

• Infants (6 weeks to <6 months): Two doses of 0.5 mL each, with an interval of 2 months between doses.
• Infants (6 months and older), children, adolescents, and adults: A single dose of 0.5 mL. An additional primary dose may be necessary for certain individuals.

Booster Doses

• Infants (6 weeks to <12 months): A booster dose at 12 months of age, with an interval of at least 2 months after the last dose.
• Individuals aged 12 months or older: A booster dose may be administered following prior vaccination with a conjugated or plain polysaccharide meningococcal vaccine.

Method of Administration

• Intramuscular injection (IM) only.
• Infants: Anterolateral thigh.
• Individuals aged 1 year and older: Anterolateral thigh or deltoid muscle.

For safe use, follow the advice of a registered physician.

✔️ Drug Interactions

• Can be administered alongside other vaccines, but ensure they are injected at different sites.
• Incompatibility: Do not mix this vaccine with other medicinal products due to the lack of compatibility studies.

✔️ Contraindications

Hypersensitivity to the vaccine's active ingredients or excipients.

✔️ Pregnancy and Lactation

• Pregnancy: Limited data available. Use only if the benefits outweigh the potential risks to the fetus.
• Lactation: Limited data on safety. Use only when necessary and the advantages outweigh the risks.

✔️ Precautions

• Delay vaccination in individuals with acute severe febrile illness. However, minor infections are not a contraindication.
• The vaccine does not protect against meningococcal serogroups other than A, C, W135, and Y.
• In individuals with impaired immune systems, the vaccine may not elicit an adequate response.
• As with any injectable vaccine, ensure appropriate medication (e.g., adrenaline) is available to manage potential anaphylactic reactions.
• Lactation: Limited data is available regarding use in breastfeeding women. Administer only if the potential benefits outweigh the risks.

✔️ Storage Conditions

• Store at 2-8°C in a refrigerator.
• Do not freeze.
• Keep iit n the original packaging to protect it from light.